R&D

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | R&D

Merck KGaA to Acquire Gamma Biosciences' Mirus Bio for $600M

Gains portfolio of RUO and GMP reagents and enhancers for a variety of applications from research through virus manufacturing at scale.

05.24.24

Breaking News | R&D

Cannovation Clinical Research Partners Launches

The newly established company is dedicated to helping bring cannabis-based drugs to market.

05.22.24

Analytical Services | Chemistry | Laboratory Testing | R&D

A New Approach to Particle Morphology

The particle size of the API and excipients affects more than just the stability and appearance of the product.

Emil W. Ciurczak, Contributing Writer 05.13.24

Bio News | Breaking News | Facilities | R&D

Solvias Announces New Biotech Site in North Carolina

The 50,000-square-foot facility will serve as Solvias’ North American hub for large molecule analytical services.

05.06.24

Breaking News | Collaborations & Alliances | R&D

Scenic Biotech Enters Research Collaboration with Bristol Myers Squibb

Aims to accelerate the development of BMS’ drug targets by identifying target biology for indication selection and expansion.

04.30.24

Breaking News | Drug Discovery | Industry News | R&D

Ono Pharmaceutical to Acquire Deciphera for $2.4B

Will enable ONO to build a robust presence in oncology, one of its key priority areas.

04.29.24

Breaking News | Collaborations & Alliances | R&D

Modalis Joins the Ginkgo Technology Network

Grants Ginkgo’s customers access to Modalis’ proprietary epigenome modulation technology, CRISPR-GNDM.

04.12.24

Breaking News | R&D

Rare Cancer Research Foundation Partners with Spanios to Advance Cancer Research

Aim to catalyze the discovery of new biomarkers and validate therapeutic approaches previously inaccessible to rare cancer patients.

04.04.24

Breaking News | Clinical Trials | R&D

WCG Launches New Application on Its ClinSphere Technology Platform

New solution is designed to alleviate the burdens faced by sites and investigators in the assessment process.

04.04.24

Why Sofgen Pharmaceuticals?

Integrated services in development, scale up, commercial manufacturing and packaging.

04.04.24

Bio News | Breaking News | Collaborations & Alliances | R&D

BostonGene Named Akoya Biosciences' Qualified CRO

Will offer end-to-end spatial biology solutions to life sciences researchers for advanced spatial proteomics analysis.

03.20.24

Breaking News | R&D

Parexel Announces CEO Transition

Jamie Macdonald will retire and transition his role as CEO to the company’s COO and Growth Officer Peyton Howell.

03.18.24

Breaking News | Promotions & Moves | R&D

CRS Clinical Research Services Appoints Dr. Elisabeth Lackner as CEO

Dr. Lackner is a highly experienced and well-respected global thought leader with over 20 years of experience in the healthcare industry.

03.15.24

R&D | Scale-up/Technology Transfer

Novel Therapeutic Manufacturing Trends

This webinar will cover the key steps and considerations involved in bringing novel nanoparticle-based therapeutics from early R&D to commercial stages.

03.04.24

Breaking News | Drug Development | Industry News | R&D

CoreRx to Acquire Societal CDMO in $130M Deal

Will create an enhanced CDMO with broad capabilities spanning early-stage formulation development through commercial manufacturing and packaging.

02.29.24

Breaking News | Collaborations & Alliances | R&D

Viatris and Idorsia Enter R&D Collaboration

Viatris to receive exclusive global development & commercialization rights to 2 Phase 3 assets as well as the potential to add additional assets in the future.

02.28.24